Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

These biggest mistakes Ozempic users have made can derail weight-loss goals and massively increase the risk of side effects.

A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration’s (FDA) drug shortage list ...

A whopping one in eight adults in the US have tried GLP-1 medications like Ozempic and Wegovy, but despite their massive popularity, many people taking the drug do so in secret. Certainly there ...

The U.S. Food and Drug Administration declared that the shortage of Novo Nordisk’s NOVO.B0.81%increase; green up pointing triangle weight-loss medications Wegovy and Ozempic has been resolved ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss. The agency ...

Novo can now meet the demand for Ozempic and Wegovy nationwide, the Food and Drug Administration said Friday. The ruling shows Novo’s confidence that the supply of Ozempic will be stable for now.

Some people have critiqued Ozempic (semaglutide)—a diabetes medication that can aid in weight loss—for the effects it has on the skin. Some people have reported "Ozempic face" and "Ozempic ...